- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Addressing Failed Patient Follow-Ups During the Pandemic
COVID-19 is an additional factor in patients shying away from follow-up exams. Nuance Communication’s Sander Kloet shares his perspectives from SIIM on addressing this issue.
One of the most widespread impacts of the COVID-19 pandemic has been the delayed study. For many patients, their screening or diagnostic studies have been put on hold for the foreseeable future. But, the postponement is more than a simple delay – it is a compounding factor that is starting to make an already existing problem worse.
It is no secret in the industry that patients who fail to arrive for follow-up care are a pervasive pain point for practices. Add in the delay, the risk, and the fear associated with the pandemic, and it is recipe for an even deeper drop in imaging volume.
Related Content: Contacting Patients About Abnormal Findings Isn’t Enough to Prompt Follow-Up
To help practices address this issue – and potentially side-step it – Diagnostic Imaging spoke with Sander Kloet, senior director of product management, diagnostics, for Nuance Communications about his session during Society for Imaging Informatics in Medicine 2020 Virtual Meeting. Here, he shares his insights on the frequency of the problem during the pandemic, strategies facilities can use to reduce the impact of failed follow-ups, and proactive tactics practices can implement.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Interventional Radiology-Led Study Shows Benefits of CT-Guided Cryoablation for Soft Tissue Sarcoma
August 1st 2024In a study involving 217 percutaneous cryoablation procedures for treating recurrent or metastatic soft tissue sarcoma in 141 patients, researchers noted an 86 percent rate of local progression-free survival and a 2 percent complication rate.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
A Victory for Radiology: New CMS Proposal Would Provide Coverage of CT Colonography in 2025
July 12th 2024In newly issued proposals addressing changes to coverage for Medicare services in 2025, the Centers for Medicare and Medicaid Services (CMS) announced its intent to provide coverage of computed tomography colonography (CTC) for Medicare beneficiaries in 2025.
